DXCM Jun 2025 110.000 put
| Previous Close | 9.20 |
| Open | 9.20 |
| Bid | 12.60 |
| Ask | 14.60 |
| Strike | 110.00 |
| Expire Date | 2025-06-20 |
| Day's Range | 9.20 - 9.20 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 197 |
Business WireDexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 Diabetes
EDINBURGH, Scotland, June 04, 2024--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in access to its products for those treating Type 2 diabetes (T2D) with basal insulin injections. The company, which pioneered CGM technology 25 years ago, has secured access to its Dexcom ONE sensor for around 100,000 T2D users in France. The reimbursement guidance offers people aged over two years who are
ZacksDexCom (DXCM) Declines on Potential Competition for Stelo
DexCom (DXCM) stock declined on Monday following the FDA approval of another over-the-counter glucose monitor, potentially fueling competition for Stelo.
Business WireNova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
BURNABY, British Columbia, June 03, 2024--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, today announced that residents of Nova Scotia living with either type 1 or type 2 diabetes who use intensive insulin and meet eligibility criteria now have coverage for Dexcom G6 and Dexcom G7 continuous glucose monitoring (CGM) systems.
